Zhitong Financial APP News, Si Taili (603520.SH) notice, the company received on October 19, 2023 Shanghai Stock Exchange listing examination Center issued a "Zhejiang Si Tai Li Pharmaceutical Co., Ltd. to a specific object of stock audit opinions notice."
The main contents of the Audit notice are as follows: Zhejiang Sili Pharmaceutical Co., Ltd. applies to issue shares to specific objects to meet the issuance conditions, listing conditions and information disclosure requirements. In addition, please state: the acquisition background of Poseidon Pharmaceutical subsidiary, the goodwill impairment testing process, the adequacy of goodwill impairment loss in 2022, and whether there is a risk of large goodwill impairment loss in the near future. Please recommend institutions and reporting accountants to check and express their clear opinions.